பூஜா திட்கே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பூஜா திட்கே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பூஜா திட்கே Today - Breaking & Trending Today

Court rejects Cutis Biotech plea against Serum Institute claiming its trademark Covishield


Court rejects Cutis Biotech plea against Serum Institute claiming its trademark Covishield
ANI |
Updated: Jan 30, 2021 23:13 IST
Pune (Maharashtra) [India], January 30 (ANI): A civil court in Pune rejected the injunction application filed on behalf of CUTIS Biotech against Serum Institute of India (SII), claiming trademark Covishield of the Covid-19 vaccine, on Saturday.
According to SII s press release, earlier this month, Cutis-Biotech, a pharmaceutical products manufacturer and seller based in Maharashtra, filed a suit in the civil court seeking to restrain SII from using the trademark Covishield or any other similar names for its COVID-19 vaccine and claimed the pharma firm is a prior user of the brand name. ....

Pooja Tidke , Hitesh Jain , Parinam Law Associates , Serum Institute Of India , Serum Institute , Managing Partner , Cutis Biotech , Parinam Law , பூஜா திட்கே , ஹிடேஷ் ஜெயின் , சீரம் நிறுவனம் ஆஃப் இந்தியா , சீரம் நிறுவனம் , நிர்வகித்தல் கூட்டாளர் , குட்டிஸ் பயோடெக் ,

Pune court rejects injunction against SII over 'Covishield' trademark


Pune court rejects injunction against SII over Covishield trademark
​ By
IANS
|
Published on
​ Sat, Jan 30 2021 22:48 IST
|
​ 0 Views
 
B desh to receive 2 mn Covishield doses from India as gift (Photo: Kuntal Chakrabarty/IANS). Image Source: IANS News
New Delhi, Jan 30 : A civil court in Pune on Saturday rejected an injunction application filed on behalf of pharmaceutical company Cutis Biotech against the Serum Institute of India, seeking the latter to restrain from using the trademark Covishield for its Covid-19 vaccine.
Earlier this month, Cutis-Biotech, a pharmaceutical products manufacturer and seller based in Maharashtra, had filed a suit in the civil court seeking to restrain SII from using the trademark Covishield or any other similar names for its Covid-19 vaccine, claiming that the pharma company is a prior user of the brand name. ....

New Delhi , Pooja Tidke , Hitesh Jain , Serum Institute Of India , Cutis Biotech , Serum Institute , Managing Partner , புதியது டெல்ஹி , பூஜா திட்கே , ஹிடேஷ் ஜெயின் , சீரம் நிறுவனம் ஆஃப் இந்தியா , குட்டிஸ் பயோடெக் , சீரம் நிறுவனம் , நிர்வகித்தல் கூட்டாளர் ,